Clinical Pediatric Emergency Medicine
Volume 6, Issue 4 , Pages 200-206 , December 2005

The Infant With Undiagnosed Cardiac Disease in the Emergency Department

  • Kathleen Brown, MD, FACEP, FAAP

      Affiliations

    • Corresponding Author InformationReprint requests and correspondence: Kathleen Brown, MD, FACEP, FAAP, Division of Emergency Medicine, Children's National Medical Center, 111 Michigan Avenue, Washington, DC 20010.

References 

  1. Savitsky E, Alejos J, Votey S. Emergency department presentations of pediatric congenital heart disease. J Emerg Med. 2003;24:239–245
  2. Woodward GA, Mahle WT, Forkey HC. Sepsis, septic shock, acute abdomen? The ability of cardiac disease to mimic other medical illness. Pediatr Emerg Care. 1996;12:317–324
  3. Wren C, Richmond S, Donaldson L. Presentation of congenital heart disease in infancy: implications for routine examination. Arch Dis Child. 1999;80:F49–F53
  4. Reich JD, Miller S, Brogdon B, et al. The use of pulse oximetry to detect congenital heart disease. J Pediatr. 2003;142:268–272
  5. Recto MR, Sobczyk WL, Yeh T. Right superior vena cava draining predominantly into the left atrium causing cyanosis in a young child. Pediatr Cardiol. 2004;25:163–164
  6. Lewis AB, Freed MD, Heymann MA, et al. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation. 1981;64:893–898
  7. Lim DS, Kulik TJ, Kim DW, et al. Aminophylline for the prevention of apnea during prostaglandin E1 infusion. Pediatrics. 2003;112:e27–e29
  8. Hellstrom-Westas L, Hanseus K, Jogi P, et al. Long-distance transports of newborn infants with congenital heart disease. Pediatr Cardiol. 2001;22:380–384
  9. Liberman L, Gersony WM, Flynn PA, et al. Effectiveness of prostaglandin E1 in relieving obstruction in coarctation of the aorta without opening the ductus arteriosus. Pediatr Cardiol. 2004;25:49–52
  10. Johnsrude CL, Perry JC, Cecchin F, et al. Differentiating anomalous left main coronary artery originating from the pulmonary artery in infants from myocarditis and dilated cardiomyopathy by electrocardiogram. Am J Cardiol. 1995;75:71–74
  11. Chang R, Allada V. Electrocardiographic and echocardiographic features that distinguish anomalous origin of the left coronary artery from pulmonary artery from idiopathic dilated cardiomyopathy. Pediatr Cardiol. 2001;22:3–10
  12. Lambert V, Touchot A, Losay J, et al. Midterm results after surgical repair of the anomalous origin of the coronary artery. Circulation. 1996;94:38–43
  13. Nehegme R. Recent developments in the etiology, evaluation and management of the child with palpitations. Curr Opin Pediatr. 1998;10:470–475
  14. Vos P, Pulles-Heintzbereger CFM, Delhaas T. Supraventricular tachycardia: an incidental diagnosis in infants and difficult to prove in children. Acta Pediatr. 2003;92:1058–1061
  15. Ko JK, Deal BJ, Strasburger JF, et al. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol. 1992;69:1028–1032
  16. Craig JE, Scholz TA, Vanderhooft SL, et al. Fat necrosis after ice application for supraventricular tachycardia termination. J Pediatr. 1998;133:727
  17. Losek JD, Endom E, Deitrich A, et al. Adenosine and pediatric supraventricular tachycardia in the emergency department: multicenter study and review. Ann Emerg Med. 1999;33:185–191
  18. Riggs TW, Byrd JA, Weinhouse E. Recurrence risk of supraventricular tachycardia in pediatric patients. Cardiology. 1999;91:25–30
  19. Etheridge SP, Judd VE. Supraventricular tachycardia in infancy: evaluation, management, and follow-up. Arch Pediatr Adolesc Med. 1999;153:267–271
  20. Sanatani S, Hamilton RM, Gross GJ. Predictors of refractory tachycardia in infants with supraventricular tachycardia. Pediatr Cardiol. 2002;23:508–512
  21. Schwartz PJ, Stramba-Badiele M, Segantini A, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med. 1998;338:1709–1714
  22. Wheeler DS, Kooy NW. A formidable challenge: the diagnosis and treatment of viral myocarditis in children. Crit Care Clin. 2003;19:365–391
  23. Levi D, Alejos J. Diagnosis and treatment of pediatric viral myocarditis. Curr Opin Cardiol. 2001;16:77–83
  24. Khan MA, Das B, Lohe A, et al. Neonatal myocarditis presenting as an apparent life threatening event. Clin Pediatr. 2003;42:649–652
  25. Inwald D, Franklin O, Cubbitt D, et al. Enterovirus myocarditis as a cause of neonatal collapse. Arch Dis Child Fetal Neonatal Ed. 2004;89:461–462
  26. Shatz A, Hiss J, Arsenberg B. Myocarditis misdiagnosed as sudden infant death syndrome. Med Sci Law. 1997;37:16–18
  27. Grangeot-Keros L, Broyer M, Briand E, et al. Enterovirus in sudden unexpected deaths in infants. Pediatr Infect Dis J. 1996;15:123–128
  28. Dettmeyer R, Baasner A, Schlamann M, et al. Role of virus induced myocardial affections in sudden infant death syndrome: a prospective postmortem study. Pediatr Res. 2004;55:947–952
  29. Soongswang J, Durongpisitkul K, Ratanarapee S, et al. Cardiac troponin T: its role in the diagnosis of clinically suspected acute myocarditis and chronic dilated cardiomyopathy in children. Pediatr Cardiol. 2002;23:531–535
  30. Lee K, McCrindle B, Bohn D, et al. Clinical outcomes of acute myocarditis in childhood. Heart. 1999;82:226–233

PII: S1522-8401(05)00106-0

doi: 10.1016/j.cpem.2005.09.006

Clinical Pediatric Emergency Medicine
Volume 6, Issue 4 , Pages 200-206 , December 2005

Article Tools